The relative ranking of cirrhosis-related deaths differs between high-/middle-income countries. Gut microbiome is affected in cirrhosis and is related to diet. Our aim was to determine the effect of differing dietary habits on gut microbiota and clinical outcomes. Outpatient compensated/decompensated patients with cirrhosis and controls from Turkey and the United States underwent dietary and stool microbiota analysis. Patients with cirrhosis were followed till 90-day hospitalizations. Shannon diversity and multivariable determinants (Cox and binary logistic) of microbial diversity and hospitalizations were studied within/between groups. Two hundred ninety-six subjects (157 U.S.: 48 controls, 59 compensated, 50 decompensated; 139 Turkey: 46 controls, 50 compensated, 43 decompensated) were included. Patients with cirrhosis between cohorts had similar Model for End-Stage Liver Disease (MELD) scores. American patients with cirrhosis had more men, greater rifaximin/lactulose use, and higher hepatitis C/alcohol etiologies. Coffee intake was higher in Americans whereas tea, fermented milk, and chocolate intake were higher in Turkey. The entire Turkish cohort had a significantly higher microbial diversity than Americans, which did not change between their controls and patients with cirrhosis. In contrast, microbial diversity changed in the U.S.-based cohort and was the lowest in decompensated patients. Coffee, tea, vegetable, chocolate, and fermented milk intake predicted a higher diversity whereas MELD score, lactulose use, and carbonated beverage use predicted a lower microbial diversity. The Turkish cohort had a lower risk of 90-day hospitalizations. On Cox and binary logistic regression, microbial diversity was protective against 90-day hospitalizations, along with coffee/tea, vegetable, and cereal intake. Conclusion: In this study of patients with cirrhosis and healthy controls from the United States and Turkey, a diet rich in fermented milk, vegetables, cereals, coffee, and tea is associated with a higher microbial diversity. Microbial diversity was associated with an independently lower risk of 90-day hospitalizations. (HEPATOLOGY 2018;68:234-247).
C irrhosis is a leading cause of morbidity and mortality worldwide. (1, 2) However, the disease etiology and its ranking as a cause of death varies between countries. (2) In Westernized countries like the United States, it remains a major cause of mortality, whereas in other parts of the world, including middle-income countries such as Turkey, its ranking as a cause of death is relatively low. (2) In addition to income disparities, dietary practices differ widely, specifically the predominance of a Western diet in the United States and a diet rich in fermented milk products and vegetables in countries such as Turkey.
Gut microbiota have been implicated in the pathogenesis and progression of cirrhosis in several studies. (3, 4) Specifically, there is a decrease in microbial diversity that is progressive between healthy controls, compensated cirrhosis, and is the lowest in patients with decompensated cirrhosis. (3) Disease progression is accompanied by an increase in relative abundance of potentially pathogenic taxa belonging to Enterobacteriaceae whereas autochthonous taxa are lower. (3, 5) A major determinant of gut microbial composition is the diet, which is different between industrialized and other countries. (6) (7) (8) However, a detailed evaluation of dietary influences on gut microbiota and their impact on gut microbiota and outcomes in cirrhosis is unclear, especially from a multicenter perspective.
We hypothesized that diet and severity of cirrhosis interact in determining microbiota composition and ultimately hospitalizations differently across cohorts from the United States and Turkey. The aim was to compare these two populations with respect to their dietary habits and their impact on gut microbiota and clinical outcomes
Patients and Methods
Three groups of subjects, healthy controls, patients with compensated cirrhosis and outpatients with decompensated cirrhosis were recruited from centers in the United States (Virginia Commonwealth University and McGuire VA Medical Center, Richmond, Virginia) and Turkey (Ankara University School of Medicine, Ankara, Turkey). Patients were diagnosed with cirrhosis based on liver biopsy, if available, elastography, or clinical, biochemical, and radiological evidence of cirrhosis. Decompensation was defined as past variceal bleeding, ascites under treatment, hepatic encephalopathy (HE) under treatment, and those with jaundice. (9) Patients with alcohol abuse and illicit drug use (defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition [DSM-V] criteria), (10) unable to provide samples, and those who were hospitalized within the last 30 days were excluded from the study. All healthy controls were free of chronic diseases, were not on any prescription medications, and had normal liver function.
Subjects underwent a dietary evaluation over the last week, which inquired about their overall dietary preferences (vegan, vegetarian, ovo-lacto-vegetarian, or predominantly nonvegetarian) using a specifically designed food-frequency questionnaire. Specifically, we inquired about coffee, tea, caffeinated/decaffeinated carbonated drinks, fermented foods (yogurt, ayran, and curds), other dairy products (milk, cheese), eggs, cereals, and grains (breakfast cereals, rice, white bread, and wheat bread), meat intake (lamb/mutton, pork, beef, fish, poultry, and other seafood), and chocolate. Coding was performed according to serving size (Supporting Data) based on daily or >1/week frequencies depending on the food item. Past decompensating events, including variceal bleeding, HE, jaundice, and ascites as well as the presence of varices, were recorded. (11) Laboratory values (complete blood count, MELD score, serum albumin, and serum sodium) at the time of sample collection were recorded. In addition, current medications (lactulose, rifaximin, fiber supplements, proton pump inhibitors [PPIs] , nonselective beta-blockers [NSBBs], or antiviral therapy for hepatitis B) as well as lifestyle issues (smoking and alcohol history) were obtained at the same time. (12) Comorbid conditions, such as diabetes and metabolic syndrome (MetS) and history of sustained virological response (SVR) to hepatitis C therapy, were also assessed. (13, 14) Patients with cirrhosis were prospectively followed for at least 90 days for nonelective hospitalizations that
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were determined according to the supervising clinicians at each site. The 90-day interval was chosen because of the validity of the MELD score for that duration and also the high likelihood of readmissions during that interval in past cohorts. (15) Times to hospitalization from enrollment and reasons for hospitalization were prospectively recorded. Multivariable binary logistic and Cox proportional-hazards regression analyses were then performed to determine the role of diet, medications, and microbial diversity, along with cirrhosis severity on the hospitalization risks in the entire cohort and the individual U.S. and Turkish cohorts.
All subjects gave written informed consent, and the protocols were approved by the local institutional review boards of each institution.
All patients underwent stool collection for microbiota analysis. Microbial DNA were isolated from stool samples as described. (16) 16S RIBOSOMAL RNA BACTERIAL COMMUNITY ANALYSIS V1 and V2 hypervariable regions of the bacterial 16S ribosomal RNA (rRNA) gene were sequenced on a PGM Ion Torrent Next-generation sequencer using Multitag fusion primers targeting the V1-V2 region (27F: 5 0 -AGAGTTTGATCCTGGCTCAG-3 0 , 355R: 5 0 -GCTGCCTCCCGTAGGAGT-3 0 ). Amplicons for 96 samples were then sequenced together to generate >20,000 3 400 base reads per sample.
Quality Control
A negative control (water) and a known positive control were used in each batch of microbial DNA sequencing to assess laboratory variability and contamination. (17) 
OVERALL BIOINFORMATICS ANALYSIS
We used the Microbiome Analysis Center's Portal to organize raw data, track clinical metadata, and track analysis between the groups at baseline and/if they develop infections and are resampled. The portal consists of a Drupal based interface wrapped around a MYSQL database that uses PHP to manage the relational database (http://mbac.gmu.edu/mbac/display_ detail.php?tb=research&id=4). The system has built in safeguards to curate the data, keep it secure, and assure quality control. Raw 16S rRNA gene sequence data were utilized for bioinformatics analysis after chimeric sequences were removed using UChime. (18) The remaining clean 16S sequences were clustered into operational taxonomic units (OTUs) using the USEARCH algorithm. (19) A sequence identity of 97% was used to generate OTUs representing bacterial species. Taxonomic identity of reference sequences were determined using the RDP11 Classifier (20) and QIIME (Quantitative Insights Into Microbial Ecology) Pipeline. 
BIOSTATISTICAL ANALYSIS
Bacterial community composition was characterized using OTU counts generated as described above. OTU counts were converted to measures of relative abundance to account for variation in sequencing coverage between samples and compared between Turkish and U.S. samples, patients with cirrhosis and controls, and between patients with compensated and decompensated cirrhosis. Statistical analysis was carried out using the statistical software package, R (www.r-project.org). Alpha diversity (richness and evenness of taxa within a population) was reported using the Shannon Index, (22) which was used as a dependent variable using demographics, location, cirrhosis/medication measures, and dietary values on multivariable linear regression. We used linear discriminant function effect size (LEfSe) to determine the microbial taxa most likely to explain differences between the subject groups. (23) 
Results
COHORT CHARACTERISTICS Subjects U.S. and Turkish cirrhosis populations were statistically similar in age, MELD score, PPI use, and proportion with decompensated cirrhosis (Table 1 ). The American cirrhosis cohort had a higher proportion of men, those with recent alcohol use, lower serum sodium and platelet counts, NSBB use and past variceal bleeding, and those with past HE and those on lactulose and rifaximin. There was a higher proportion with past jaundice in the Turkish cohort. The etiology of cirrhosis was predominantly hepatitis C and alcohol in the United States whereas it was more related to hepatitis B in Turkey; therefore, more Turkish patients were on antivirals for hepatitis B. This indicates the regional differences in cirrhosis etiology. SVR rates, past ascites, and other blood indices were similar between groups. Turkish controls were significantly younger than all other groups.
Dietary Details
All subjects were nonvegetarian and had similar caloric intake and macronutrient proportions ( Table 2 ). The U.S. population largely followed a Western diet with relatively low consumption of fermented foods, pork, and high coffee consumption ( Table 2 ). The U.S. population also had more fish and pork consumption. There was also higher carbonated drink consumption in the United States compared to Turkish patients with cirrhosis. On the other hand, the Turkish cohort consumed a diet approximating, but not really a complete, Mediterranean diet, which was rich in fermented foods such as yogurt and vegetables. In addition, they demonstrated a higher tea consumption as well as avoidance of pork and alcohol. A relatively higher coffee and carbonated drink consumption and lower tea and fermented milk product consumption was noted in Turkish controls, who were significantly younger than their counterparts with cirrhosis.
MICROBIOTA CHANGES
Comparison Between the U.S. and Turkish Cohorts
Shannon diversity indices were significantly lower in decompensated cirrhosis compared to compensated patients and controls in the American cohort, but were statistically similar in the Turkish cohort (Fig. 1A) . The U.S.-based controls, patients with compensated cirrhosis, and patients with decompensated cirrhosis had a lower diversity compared to their Turkish counterparts. Hospitalizations are within 90 days of enrollment and sample collection. Data are presented as raw numbers except in age, MELD score, serum albumin, and sodium, which are presented as mean 6 SDs. Alcohol use was defined as any alcohol intake during the dietary recall period that was short of the DSM-V definitions. *P < 0.05 within the same population. † P < 0.05 between United States and Turkey. Abbreviations: WBC, white blood cell; Decomp, decompensated; NASH, nonalcoholic steatohepatitis.
Weighted UNIFRAC values were significantly different between controls, patients with compensated cirrhosis, patients with decompensated cirrhosis when U.S. and Turkish cohorts were compared (P <5 1.0e-02). On LEFSe analysis shown in Fig. 1B -D, specific taxa were different between cohorts at each stage of the disease. Constituents of Betaproteobacteria, which has been found in the intestinal tract of healthy humans, and Kiloniellaceae, found around plants such as coffee and sugarcane, were higher and Coriobacteriaceae, which could play a role in inflammatory bowel disease, were lower in Turkish subjects at each stage of the disease. In the decompensated stage, Turkish patients had a higher representation of beneficial taxa such as Ruminococcaceae and other Clostridiales and a lower relative abundance of Enterococcaceae compared to U.S.-based patients. Similar changes were also observed in the compensated stage when beneficial taxa such as Bifidobacteriaceae, in addition to the ones in decompensated stage, were higher in the Turkish cohort.
EFFECT OF DEMOGRAPHICS, MEDICATIONS, AND LIFESTYLE ON GUT MICROBIOTA IN THE ENTIRE COHORT
Weighted UNIFRAC showed that in the entire group, a significant difference in gut microbiota was seen in those on lactulose, rifaximin, PPIs, NSBBs, and fiber supplements individually (all P <5 1.0e-02) compared to the patients not on these medications. Gut microbiota were also affected by sex, alcohol use, and smoking (all P <5 1.0e-02) in the entire group. When Shannon diversity values were compared, there was a significantly lower diversity in men (women 7.6 6 1.3 vs. men 7.1 6 1.3; P 5 0.005), those on rifaximin (7.4 6 1.2 vs. 6.3 6 1.5, P < 0.0001), and lactulose (7.4 6 1.2 vs. 6.4 6 1.7; P < 0.0001). There was a trend toward lower diversity in those on NSBBs (7.3 6 1.4 vs. 6.9 6 1.5; P 5 0.09), with past ascites (7.2 6 1.3 vs. 6.9 6 1.7; P 5 0.19), and past variceal Data are presented as raw numbers of subjects coded 5 1 over the last week apart from the caloric intake values, which are presented as mean 6 SD. *P < 0.05 within the same population. † P < 0.05 between United States and Turkey. Abbreviations: Comp, compensated; Decomp, decompensated. bleeding (7.2 6 1.4 vs. 6.6 6 1.7; P 5 0.08). A higher diversity was observed in patients on hepatitis B virus (HBV) antivirals (6.5 6 1.5 vs. 7.7 6 1.0; P < 0.001) and those with SVR from hepatitis C virus (HCV; 6.5 6 1.5 vs. 7.5 6 1.0; P 5 0.002). No significant differences were noted with recent alcohol use (7.3 6 1.3 vs. 7.1 6 1.4; P 5 0.55), PPIs (7.4 6 1.3 vs. 7.1 6 1.3; P 5 0.11), diabetes (7.1 6 1.5 vs. 7.2 6 1.3; P 5 0.49), MetS (7.2 6 1.4 vs. 6.9 6 1.4; P 5 0.22), presence of varices (7.2 6 1.4 vs. 7.0 6 1.6; P 5 0.42), past jaundice (7.161.4 vs 7.361.6, P 5 0.74) or fiber use (7.361.3 vs 6.961.3, P 5 0.48).
EFFECT OF DIET ON GUT MICROBIOTA IN THE ENTIRE COHORT
On weighted UNIFRAC, there were significant differences in all aspects of the diet studied (all P <5 1.0e-02), except for white bread. There was a higher diversity in subjects who consumed more tea (6.8 6 1.2 vs. 7.6 6 1.3; P < 0.0001), fermented milk products (6.8 6 1.4 vs. 7.8 6 1.0; P < 0.0001), vegetables (6.7 6 1.4 vs. 7.4 6 1.3; P 5 0.05), eggs (6.9 6 1.4 vs. 7.5 6 1.2; P < 0.0001), wheat bread (7.0 6 1.3 vs. 7.7 6 1.2; P < 0.0001), rice (7.1 6 1.3 vs. 7.6 6 1.2; P 5 0.012), chocolate (7.0 6 1.4 vs. 7.7 6 1.1; P < 0.0001), coffee (7.5 6 1.1 vs. 7.1 6 1.3; P 5 0.05), and lamb (7.1 6 1.4 vs. 8.0 6 0.7; P < 0.0001).
Diversity was lower for those who consumed more caffeinated (7.4 6 1.3 vs. 7.0 6 1.4; P 5 0.05) and decaffeinated carbonated drinks (7.3 61.3 vs. 6.5 6 1.5; P 5 0.01), pork (7.5 6 1.4 vs. 6.8 6 1.2; P < 0.0001), poultry (7.6 6 1.2 vs. 7.2 6 1.3; P 5 0.04) compared to the rest. No change was observed with milk (7.2 6 1.4 vs. 7.3 6 1.2; P 5 0.31), fruits (7.0 6 1.3 vs. 7.3 6 1.3; P 5 0.08), breakfast cereals (7.3 6 1.4 vs. 7.1 6 1.2; P 5 0.13), white bread (7.3 6 1.4 vs. 7.2 6 1.3; P 5 0.68), cheese (7.0 6 1.3 vs. 7.3 6 1.3; P 5 0.18), beef (7.3 6 1.5 vs. 7.3 6 1.3; P 5 0.95), fish (7.2 6 1.4 vs. 7.4 6 1.3; P 5 0.29), or other seafood (7.3 6 1.3 vs. 7.2 6 1.3; P 5 0.78). A variable was created with no coffee/tea, either coffee/tea, or both, and on analysis of variance, this was associated with a higher diversity in any coffee/tea drinkers (no 6.5 6 1.3 either 7.3 6 1.2 vs. both 7.4 6 1.5; P < 0.0001). There was no inverse relationship between coffee/tea and alcohol intake.
MULTIVARIABLE DETERMINANTS OF SHANNON DIVERSITY IN THE ENTIRE COHORT
For the entire cohort, the significantly different variables between the groups were entered with Shannon diversity as the dependent variable. We did not include U.S./Turkey location and MELD score in order to determine the effect of diet and also to not exclude controls from the ultimate model. The significant variables were fermented milk products (P < 0.001), chocolate (P 5 0.04), tea (P 5 0.05), and whole-wheat bread (P 5 0.04) associated with higher diversity and decompensated status (P < 0.0001) use, and carbonated decaffeinated beverage (P 5 0.02) were associated with a lower diversity. When a similar analysis was performed with only the patients with cirrhosis in both cohorts, the results were largely similar. Fermented milk product intake (P < 0.001), cereals (P 5 0.02), whole-wheat bread (P 5 0.05), and chocolate (P 5 0.013) were associated with higher diversity whereas white bread (P 5 0.005), past ascites (P 5 0.013), smoking (P 5 0.04), and MELD score (P < 0.0001) were predictive of a lower diversity.
Within the American Cohort
The Shannon diversity reduced with disease progression, which was also noted on weighted UNI-FRAC where controls, patients with compensated cirrhosis, and patients with decompensated cirrhosis were significantly different (all P <5 1.0e-02) from one another. On LEFSe ( Fig. 2A-C) , controls had higher autochthonous taxa belonging to Clostridiales, whereas patients with decompensated cirrhosis had higher Lactobacillaceae, Veillonellaceae, and Fusobacteria. A similar pattern was noted in the controls versus compensated comparison, where, in addition to Lactobacillaceae, Veillonellaceae, Fusobacteria, and Streptococcaceae were also higher in patients with cirrhosis. Patients with compensated cirrhosis and patients with decompensated cirrhosis differed in the U.S. cohort with respect to higher autochthonous taxa (Lachnospiraceae and other Clostridiales members) and lower Veillonellaceae and Bifidobacteriaceae in patients with compensated cirrhosis. Predictors for Shannon diversity were coffee/tea (P 5 0.02), cereals (P 5 0.001), and chocolate (P 5 0.03), which were associated with higher diversity, whereas decompensated status (P < 0.001) and white bread intake (P 5 0.01) were predictive of a lower diversity.
Within the Turkish Cohort
Whereas there was no significant difference in Shannon diversity between the groups within the Turkish cohort, on weighted UNIFRAC, controls, patients with compensated cirrhosis, and patients with decompensated cirrhosis were significantly different (all P <5 1.0e-02) from one another. Comparing the specific taxa on LEFSe (Fig. 2D-F) , patients with decompensated cirrhosis had higher Streptococcaceae and Sutterellaceae and lower Enterococcaceae compared to patients with compensated cirrhosis. When controls were compared to patients with compensated cirrhosis, there was a higher Enterobacteriaceae, Streptococcaceae, and Veillonellaceae in patients with cirrhosis. Similarly, Enterobacteriaceae and Streptococcaceae were higher in patients with decompensated cirrhosis, but Enterococcaceae, Veillonellaceae, and autochthonous taxa were higher in controls. On regression, determinants of Shannon diversity were vegetable consumption (P 5 0.001) and chocolate (P 5 0.02), which were associated with higher diversity, and decaffeinated carbonated drinks (P 5 0.01) were associated with lower diversity.
HOSPITALIZATIONS
There was a statistically higher number of hospitalizations, all-cause and liver-related, between the Turkish and U.S. cohorts (P 5 0.016 all-cause and P 5 0.02 liver-related; Table 1 ). The leading causes of hospitalizations in the U.S. cohort were infections (n 5 7), HE (n 5 6), acute kidney injury/ascites (n 5 6), upper gastrointestinal bleeding (n 5 3), hepatocellular carcinoma (HCC)-related (n 5 3), coronary artery disease (n 5 2), and other liver-unrelated causes (n 5 2). In the Turkish cohort, the reasons for hospitalization were acute kidney injury/ascites (n 5 7, pancytopenia (n 5 2, HCC-related (n 5 1, and liverunrelated (n 5 2). Time for hospitalization after enrollment was 46.8 6 31.9 days, which was similar in American compared to Turkish patients (40.9 6 31.1 vs. 57.3 6 31.4; P 5 0.14). Hospitalized patients had a significantly lower Shannon diversity index compared to the rest (6.6 6 1.8 vs. 7.3 6 1.3; P 5 0.02), and there was a significant correlation between diversity and time to hospitalization (r 5 0.59; P < 0.0001) in those who got hospitalized. There was no significant correlation between length of stay during the ultimate hospitalization and diversity (r 5 0.12; P 5 0.4).
For Cox proportional-hazards modeling and logistic regression for all-cause hospitalization, variables were divided into clinical (age, male gender, MELD, smoking, diabetes, albumin, Na, past ascites, past HE, past variceal bleed, past jaundice, and presence of varices), Treatments (lactulose, rifaximin, PPIs, beta-blockers, fiber supplement, hepatitis B antivirals, and SVR), diet (coffee/tea, yogurt, milk, fruits, vegetables, eggs, cheese, rice, cereals, bread-white, bread-whole wheat, bread-other, lamb, pork, beef, fish, other seafood, poultry, caffeinated carbonated drinks, decaffeinated carbonated drinks, alcohol, and chocolate), and Shannon diversity. Because of this large number of variables, separately, for each domain, a backward elimination procedure was performed with a Cox proportional-hazards regression model where any variable significant at the P < 0.20 significance level was retained. The variables that were retained using this criterion for each domain (clinical: MELD, past ascites, and presence of varices; treatment: PPI and NSSBs; diet: vegetables, rice, cereals, and breadwhole wheat) were then placed into a model simultaneously and then another backward elimination Cox proportional-hazards regression model was performed, this time retaining variables significant at the P < 0.05 significance level. The final model at this stage included MELD, PPIs, past ascites, vegetables, and cereals. When Shannon index was added, the final model that was significant consisted of Shannon index (protective), PPIs, past ascites, vegetables, and cereals intake (Table 3) .
A similar method was adopted for logistic regression, where the variables that were retained using this criterion for each domain (clinical: MELD, past ascites; treatment: lactulose and NSSBs; diet: vegetables, cereals, and coffee/tea) were then placed into a model simultaneously and then another backward elimination logistic regression model was performed, this time retaining variables significant at the P < 0.05 significance level. The variables significant at this stage were MELD, cereals, vegetables, coffee/tea, and past ascites. When Shannon index was introduced, the significant model consisted of diversity, cereals, vegetables, coffee/ tea, and past ascites (Table 4 ).
Discussion
The current results demonstrate that patients with cirrhosis have microbial profiles that are highly responsive to the underlying dietary practices. Compared to the United States, Turkish subjects with cirrhosis have a different microbiota that occurs not only in patients with cirrhosis, but also in healthy controls. The significant changes in gut bacterial diversity within the U.S.-based cohort with advancing cirrhosis, but not in Turkey, is instructive of the role that diet plays in the ultimate microbiota composition of the gut.
The central role of the diet in modulating the gut microbiota has been recognized extensively in healthy and diseased individuals. (7, 24) Indeed, microbiota composition is profoundly affected as a result of a switch from plant-based to animal-based diets and vice versa to an extent that would obliterate any disease-related impact. (6) This also stems from the microbiota being a reactive organ that is dynamic with both longer-term ecological and short-term dietary pressures. (24) However, the detailed impact of diet on the microbiota has not been studied systematically in liver cirrhosis. Cirrhosis is the end result of multiple hepatic insults that culminates in a significant disruption in the gut-liver axis. (25) As a result of impaired bile secretion and the generalized immunosuppressive state in advancing cirrhosis, gut microbiota proliferate and their products adversely impact the intestinal barrier, systemic inflammatory profile, and ultimately the prognosis. (26) The effect of diet on the gut-liver axis is important because of the liver's central role in metabolism and the role of alcohol and fatty liver disease as causes of cirrhosis. (25) There is also increasing epidemiological evidence that sources of dietary phenols, such as coffee and tea, can modulate MetS and fatty liver disease. Also, probiotics and yogurt have been shown to affect disease progression in cirrhosis, and a Mediterranean diet can modulate risk of fatty liver disease. (27) (28) (29) Even though the Turkish cohort was not strictly following a Mediterranean diet and was similar on an overall macronutrient distribution, there were important differences in the dietary constituents.
We found, in the entire group, that the plant phenol-containing dietary compounds, such as tea, coffee, and chocolate, had a consistent beneficial effect on microbial diversity, which, in turn, was associated with a lower risk of hospitalizations. (30) In addition, use of fermented milk products (yogurt in the United States and yogurt and ayran in Turkey) was also associated with a beneficial increase in microbiota diversity in cirrhosis, as has been reported in past studies of patients without cirrhosis. (8) The relative uniformity of tea, chocolate, and fermented milk products across controls, patients with compensated cirrhosis, and patients with decompensated cirrhosis could be a possible explanation of the similar diversity in the Turkish cohort. This was complemented by relatively lower fermented milk product and chocolate consumption in the U.S. cohort, although coffee consumption was higher than the Turkish subjects. In addition to these dietary differences, the American cohort also had a higher proportion of men and of patients with advanced cirrhosis, all of which, in turn, can affect microbiota composition and diversity. In addition, reflecting the underlying etiology, hepatitis B was more prevalent in the Turkish cohort, rather than alcohol and hepatitis C in the U.S. cohort. Of note, treatment of viral disease (HBV antiviral therapy and SVR from HCV) was associated with better microbial diversity. Given that this is not a before/after analysis, it could be related to more HBV patients being in the Turkish cohort, which nevertheless had a higher diversity and the comparison of HCV against non-HCV etiologies such as alcohol and nonalcoholic fatty liver disease, which typically have greater dysbiosis. (3) Regardless of these findings, HBV antiviral therapy and SVR from HCV were not significant on multivariable regression for microbial diversity and neither were independently significant in predicting hospitalizations. However, the multivariable analysis, which took all the demographic, disease severity and etiology, medication, and dietary history into account, still demonstrated the potential protective effect of microbial diversity along with vegetable and cereal intake. Importantly, these protective effects were still apparent when the U.S. and Turkish cohorts were analyzed individually with respect to diversity.
Because diversity is only one of the measures to study microbiota composition, other measures such as weighted UNIFRAC and specific taxa changes using LEFSe were also analyzed. Despite similar diversities in the Turkish subcohorts, there still remained significant differences on weighted UNIFRAC and LEFSe. This was accompanied by changes across the disease spectrum in the individual taxa in the Turkish subjects that was qualitatively different from their American counterparts. Therefore, there continued to be differences in microbiota composition across the disease spectrum in both cohorts, but the bacterial taxa driving the changes were different and were presumably not enough in type and variety to affect the diversity in the Turkish cohort.
Although it is tempting to focus on the diet as the major determinant of the microbial and disease-related change, ultimately all prognostic and diversity indices were also inherently linked to cirrhosis. Specifically, advanced-cirrhosis-related complications were major determinants of diversity and hospitalizations. (11) This is relevant because prevention of hospitalizations in cirrhosis is a major unmet need. Indeed, the rate of hospitalizations was lower in the Turkish cohort compared to the U.S.-based cohort, despite a similar MELD score, which could be partly related to the higher proportion of American patients on lactulose.
However, the multivariable analysis demonstrated that coffee/tea, vegetable, and cereal intake, along with microbial diversity, were protective against hospitalizations. Dietary advice to most patients with cirrhosis currently is focused on sodium restriction in patients with cirrhosis and general rules to avoid alcohol, increase protein intake, and additionally restrict fats in overweight individuals. (31) Trials have also shown that optimizing nutrition can improve cognition in patients with compensated cirrhosis. (32, 33) There is emerging evidence regarding the beneficial impact of coffee, tea, and caffeine on microbial diversity in population-based studies. (8) There is an association with coffee with protection against the development of hepatitis C and alcoholic cirrhosis. (34, 35) Coffee intake was also associated with a reduction in cirrhosis-associated mortality and progression of cirrhosis, whereas alcohol had the opposite impact. (36, 37) Our population had few active drinkers, and there was no consistent inverse relationship between alcohol and coffee/tea intake. Although the mechanism is unclear, nutrient absorption as well as microbiota modification with expansion of Bifidobacteria in states of precirrhosis states have been demonstrated. (38) Chocolate has also been shown to improve the portal hypertensive dynamics in patients with cirrhosis in a prospective trial, in which gut-based products have also played a role. (39) We extended these results in two different populations of patients with cirrhosis of all etiologies. When the populations were studied together or separate, chocolate, coffee, and tea intake favorably modulated the bacterial diversity, and their impact was stronger on the multivariable analysis compared to fermented milk product intake. This is unlikely to be simply related to caffeine given that caffeinated carbonated beverages did not have a similar effect. A small study in patients with precirrhosis showed that Mediterranean diet was associated with lower hepatic steatosis, but this needs to be studied in patients with cirrhosis. (40) These results are interesting because fermented milk products and chocolate, which were associated with a high microbial diversity, did not remain significant modulators of hospitalization on multivariable regression. This is likely attributed to diversity being a collinear variable and could signify the translation of better dietary constituents into greater microbial health and potentially better outcomes. However, coffee/tea, vegetables, and cereals remained protective despite adding Shannon diversity into the hospitalization prediction, indicating that other mechanisms beyond microbial diversity modulation could be behind their protective impact. We could speculate that a higher consumption of these dietary components could potentially be a reason behind the widely differing importance of cirrhosis between the United States and Turkey, although further studies are needed.
Our data are limited by the use of the dietary intake only over the last week, and we simplified the structure of the dietary analysis to a yes/no rather than a dosebased study. There was also a substantial variation between the diets of the Turkish and U.S.-based cohorts; however, ultimately, cirrhosis-related variables remained the strongest predictors of hospitalizations. The reasons for hospitalization were different between Turkey and the United States, which could be related to the underlying more advanced nature of the U.S.-based cohort given that this study was performed prospectively and hospitalizations were determined by local practices of the hospitals. We did not perform metabolomics to specifically define the mechanism of potential reasons behind the role of coffee, tea, and chocolate in modulating these outcomes.
We conclude that diet is strongly associated with microbial composition in cirrhosis. The relative impact of diet on gut microbial diversity is greater with the Turkish diet compared to Western diets compared to cirrhosis stage diagnosis given the similar diversity in Turkish controls, patients with compensated cirrhosis and patients with decompensated cirrhosis. A diet rich in fermented milk products, coffee, tea, and chocolate is associated with a higher microbial diversity, which, in turn, is associated with a lower risk of hospitalizations in an international cohort of patients with cirrhosis. Further studies are required to define whether a dedicated dietary intervention focused on increasing vegetable, coffee, tea, and whole-grain cereal intake in patients with cirrhosis following a Western diet can improve the diversity and reduce hospitalizations.
